Vistagen Therapeutics Inc expected to post a loss of $1.50 a share - Earnings Preview

Vistagen Therapeutics

19/06/2023 12:02

* Vistagen Therapeutics Inc  VTGN.OQ   VTGN.O  is expected
to show
a fall in quarterly revenue when it reports  results on June 21
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Vistagen
Therapeutics Inc
is for a loss of $1.50 per share. 
    * The one available analyst rating on the shares is
"hold".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Vistagen
Therapeutics Inc is $6​, above​ its last closing price of $2.10.
​​​

This summary was machine generated June 19 at 11:01 GMT.  All
figures in US dollars  unless otherwise stated